Stage FocusSeries A, Series B+
GeographyEurope
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Fund+ is a Belgian life sciences venture fund founded in May 2015 by the private foundation Désiré Collen and the non-profit Life Sciences Research Partners, structured as a Belgian NV/SA and based in Leuven, with a stated focus on Belgium. It invests in innovative life sciences companies — primarily therapeutics, along with diagnostics and medical devices — that have already reached proof of conc...
Notable Investments
T
TubulisC
Cardior PharmaceuticalsO
Ona TherapeuticsT
TargED BiopharmaceuticalsC
Confo TherapeuticsC
Coave TherapeuticsM
Minoryx TherapeuticsN
Novadip BiosciencesE
EPICS TherapeuticsE
EyeD PharmaceuticalsE
Egle TherapeuticsA
Astrivax TherapeuticsSimilar Funds
AP
AdBio Partners
Paris, France
Pure DeepTechBiotechSynthetic BiologyMedtechSeedSeries A
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A
HV
Hadean Ventures
Oslo, Norway
Pure DeepTechBiotechMedtechAIPre-SeedSeed
NV
Navigare Ventures
Stockholm, Sweden
Pure DeepTechBiotechSemiconductorsAdvanced MaterialsSeedSeries A
+C
+ND Capital
Woodside, CA, United States
Pure DeepTechBiotechAdvanced MaterialsSemiconductorsSeedSeries A